Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Febrile Neutropenia × Tazobactam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 2 Waldenstrom Macroglobulinemia 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Other Infectious Diseases 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Infections 1 Hot Flashes 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Fever 1 Febrile Neutropenia 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

pegylated granulocyte colony-stimulating factor 3 pegfilgrastim 3 Vancomycin 3 Interleukin 1 Receptor Antagonist Protein 2 Filgrastim 2 Ceftazidime 2 Cefepime 2 Amikacin 2 Vaccination 1 Teicoplanin 1 Tazobactam 1 Surveys and Questionnaires 1 Sodium Chloride 1 Positron Emission Tomography Computed Tomography 1 Pneumococcal Vaccines 1 Piperacillin 1 N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1 Linezolid 1 Itraconazole 1 Injections 1 Cloxacillin 1 Ciprofloxacin 1 Bevacizumab 1 Anti-Bacterial Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡